| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Helper-Inducer | 26 | 2018 | 219 | 5.320 |
Why?
|
| Cell Differentiation | 38 | 2018 | 4116 | 1.760 |
Why?
|
| Interleukins | 11 | 2018 | 341 | 1.430 |
Why?
|
| Lymphocyte Activation | 24 | 2018 | 1723 | 1.430 |
Why?
|
| Interleukin-17 | 16 | 2015 | 255 | 1.360 |
Why?
|
| Germinal Center | 10 | 2018 | 167 | 1.340 |
Why?
|
| T-Lymphocytes | 16 | 2021 | 3949 | 1.300 |
Why?
|
| Interleukin-4 | 6 | 2016 | 290 | 1.300 |
Why?
|
| Immune Tolerance | 8 | 2019 | 427 | 1.300 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 11 | 2009 | 170 | 1.260 |
Why?
|
| CD4-Positive T-Lymphocytes | 12 | 2017 | 1051 | 1.160 |
Why?
|
| Autoimmunity | 8 | 2018 | 267 | 1.070 |
Why?
|
| Th2 Cells | 5 | 2017 | 252 | 0.970 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 875 | 0.970 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2022 | 1655 | 0.970 |
Why?
|
| Gene Expression Regulation | 16 | 2019 | 4130 | 0.930 |
Why?
|
| T-Lymphocyte Subsets | 9 | 2014 | 593 | 0.930 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2024 | 131 | 0.860 |
Why?
|
| Cell Lineage | 10 | 2013 | 701 | 0.810 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2011 | 1137 | 0.740 |
Why?
|
| Arthritis | 1 | 2022 | 148 | 0.740 |
Why?
|
| CD28 Antigens | 6 | 2009 | 202 | 0.700 |
Why?
|
| Mice, Knockout | 29 | 2017 | 5728 | 0.670 |
Why?
|
| Animals | 67 | 2024 | 61956 | 0.660 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2017 | 714 | 0.650 |
Why?
|
| Mice | 57 | 2022 | 35600 | 0.600 |
Why?
|
| STAT6 Transcription Factor | 2 | 2015 | 68 | 0.590 |
Why?
|
| Th17 Cells | 7 | 2017 | 163 | 0.580 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 7 | 2017 | 39 | 0.580 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 12 | 2017 | 78 | 0.580 |
Why?
|
| Antigens | 1 | 2017 | 281 | 0.560 |
Why?
|
| Immunotherapy | 5 | 2024 | 3557 | 0.560 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 3 | 2015 | 63 | 0.560 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2017 | 228 | 0.540 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 440 | 0.540 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 550 | 0.510 |
Why?
|
| B-Lymphocytes | 11 | 2019 | 1424 | 0.480 |
Why?
|
| Asthma | 5 | 2017 | 895 | 0.450 |
Why?
|
| B7-1 Antigen | 4 | 2009 | 84 | 0.450 |
Why?
|
| Signal Transduction | 18 | 2018 | 12103 | 0.440 |
Why?
|
| Neoplasms | 7 | 2024 | 15927 | 0.410 |
Why?
|
| Vaccination | 2 | 2017 | 1166 | 0.400 |
Why?
|
| Antigen-Presenting Cells | 2 | 2011 | 286 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 22 | 2019 | 7100 | 0.390 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 8 | 2017 | 96 | 0.390 |
Why?
|
| Colitis | 3 | 2024 | 341 | 0.380 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 226 | 0.370 |
Why?
|
| Autoantigens | 1 | 2011 | 248 | 0.340 |
Why?
|
| NFATC Transcription Factors | 2 | 2007 | 96 | 0.330 |
Why?
|
| CD3 Complex | 1 | 2010 | 320 | 0.330 |
Why?
|
| DNA-Binding Proteins | 7 | 2014 | 5002 | 0.320 |
Why?
|
| Lymphoma | 1 | 2017 | 1519 | 0.320 |
Why?
|
| Adoptive Transfer | 6 | 2017 | 431 | 0.320 |
Why?
|
| Cytokines | 7 | 2019 | 2825 | 0.310 |
Why?
|
| Interleukin-12 | 1 | 2009 | 267 | 0.310 |
Why?
|
| Interferon Regulatory Factors | 4 | 2013 | 75 | 0.310 |
Why?
|
| Proteins | 3 | 2008 | 2043 | 0.310 |
Why?
|
| Receptors, Interleukin-21 | 2 | 2017 | 14 | 0.300 |
Why?
|
| B7-2 Antigen | 1 | 2007 | 53 | 0.290 |
Why?
|
| Interleukin-6 | 7 | 2022 | 1050 | 0.290 |
Why?
|
| Autocrine Communication | 1 | 2007 | 88 | 0.280 |
Why?
|
| Receptors, Immunologic | 4 | 2017 | 313 | 0.280 |
Why?
|
| Transcription, Genetic | 9 | 2019 | 3339 | 0.280 |
Why?
|
| Antibody Formation | 5 | 2012 | 386 | 0.280 |
Why?
|
| Lymphopenia | 1 | 2009 | 211 | 0.270 |
Why?
|
| Receptors, Thyroid Hormone | 4 | 2008 | 109 | 0.240 |
Why?
|
| STAT3 Transcription Factor | 6 | 2018 | 1136 | 0.230 |
Why?
|
| Flow Cytometry | 6 | 2017 | 3045 | 0.230 |
Why?
|
| Forkhead Transcription Factors | 3 | 2017 | 763 | 0.230 |
Why?
|
| Receptors, Retinoic Acid | 4 | 2008 | 367 | 0.220 |
Why?
|
| Collagen Type II | 1 | 2003 | 38 | 0.210 |
Why?
|
| Humans | 37 | 2024 | 270740 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2012 | 5438 | 0.210 |
Why?
|
| Thyroid Neoplasms | 2 | 2024 | 1894 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 3597 | 0.210 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2017 | 488 | 0.200 |
Why?
|
| Iodine Radioisotopes | 1 | 2024 | 387 | 0.200 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 3 | 2008 | 22 | 0.200 |
Why?
|
| Immunologic Memory | 4 | 2017 | 380 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-maf | 3 | 2013 | 21 | 0.200 |
Why?
|
| Mice, Transgenic | 10 | 2017 | 4223 | 0.190 |
Why?
|
| Immunity | 1 | 2003 | 354 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 5 | 2014 | 126 | 0.190 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2023 | 291 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 269 | 0.170 |
Why?
|
| Cells, Cultured | 9 | 2017 | 5694 | 0.170 |
Why?
|
| Inflammation | 6 | 2008 | 2518 | 0.170 |
Why?
|
| Interferon-gamma | 3 | 2017 | 1179 | 0.170 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2024 | 625 | 0.170 |
Why?
|
| Chondrocalcinosis | 1 | 2019 | 26 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 48 | 0.160 |
Why?
|
| Pneumonia | 2 | 2021 | 796 | 0.160 |
Why?
|
| STAT4 Transcription Factor | 1 | 2017 | 13 | 0.150 |
Why?
|
| Myeloid Cells | 2 | 2022 | 273 | 0.150 |
Why?
|
| Ovalbumin | 2 | 2015 | 390 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2003 | 496 | 0.150 |
Why?
|
| Killer Cells, Natural | 2 | 2016 | 965 | 0.140 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 1441 | 0.140 |
Why?
|
| Receptors, LDL | 1 | 2017 | 111 | 0.140 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 108 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 507 | 0.140 |
Why?
|
| Inflammation Mediators | 2 | 2009 | 401 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 3438 | 0.130 |
Why?
|
| Mycobacterium bovis | 1 | 2016 | 68 | 0.130 |
Why?
|
| Transcription Factor AP-1 | 2 | 2019 | 249 | 0.130 |
Why?
|
| GATA3 Transcription Factor | 2 | 2014 | 144 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2012 | 42 | 0.130 |
Why?
|
| Phosphopeptides | 1 | 2015 | 72 | 0.130 |
Why?
|
| Latent Tuberculosis | 1 | 2016 | 86 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2015 | 968 | 0.130 |
Why?
|
| src Homology Domains | 1 | 2015 | 133 | 0.120 |
Why?
|
| Genome | 1 | 2019 | 690 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 185 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2014 | 24 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2015 | 6390 | 0.120 |
Why?
|
| Receptors, CCR6 | 2 | 2017 | 24 | 0.120 |
Why?
|
| Immunity, Mucosal | 1 | 2015 | 121 | 0.120 |
Why?
|
| Immunoglobulin A | 1 | 2015 | 271 | 0.110 |
Why?
|
| Gene Expression | 5 | 2018 | 3640 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 189 | 0.110 |
Why?
|
| Guanylate Cyclase | 1 | 2013 | 78 | 0.110 |
Why?
|
| Immunoprecipitation | 3 | 2014 | 589 | 0.110 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2013 | 109 | 0.110 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2021 | 1335 | 0.110 |
Why?
|
| Receptors, CXCR5 | 4 | 2014 | 29 | 0.110 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 248 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3216 | 0.100 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2012 | 21 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2014 | 247 | 0.100 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 1111 | 0.100 |
Why?
|
| Complement C3 | 1 | 2012 | 80 | 0.100 |
Why?
|
| RNA, Small Untranslated | 1 | 2012 | 32 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2014 | 579 | 0.100 |
Why?
|
| Self Tolerance | 1 | 2011 | 18 | 0.100 |
Why?
|
| Lung | 3 | 2022 | 3298 | 0.100 |
Why?
|
| Autoimmune Diseases | 3 | 2010 | 436 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2014 | 2422 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1402 | 0.090 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 79 | 0.090 |
Why?
|
| Triterpenes | 1 | 2011 | 68 | 0.090 |
Why?
|
| Macrophages | 1 | 2017 | 1350 | 0.090 |
Why?
|
| Th1 Cells | 1 | 2012 | 259 | 0.090 |
Why?
|
| B7 Antigens | 2 | 2009 | 84 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2012 | 255 | 0.090 |
Why?
|
| Tuberculosis | 1 | 2017 | 613 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1580 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2012 | 498 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2014 | 1461 | 0.090 |
Why?
|
| Biomarkers | 2 | 2019 | 5051 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 655 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 628 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1456 | 0.090 |
Why?
|
| Immunoglobulin G | 3 | 2014 | 1129 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 95 | 0.090 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2009 | 18 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2017 | 912 | 0.080 |
Why?
|
| Interleukin-1 | 2 | 2009 | 475 | 0.080 |
Why?
|
| Lymphoid Tissue | 1 | 2009 | 102 | 0.080 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2000 | 168 | 0.080 |
Why?
|
| Peptide Fragments | 3 | 2017 | 1309 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 5149 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2009 | 73 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 1105 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 1642 | 0.080 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2008 | 115 | 0.080 |
Why?
|
| Immunoglobulins | 1 | 2009 | 286 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2010 | 895 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 4961 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 160 | 0.080 |
Why?
|
| Thymus Gland | 2 | 2008 | 311 | 0.080 |
Why?
|
| Mutation | 5 | 2018 | 15912 | 0.080 |
Why?
|
| Graft vs Host Disease | 2 | 2012 | 2810 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2009 | 300 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 164 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 12033 | 0.070 |
Why?
|
| Cell Communication | 1 | 2010 | 512 | 0.070 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 3156 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 466 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 2454 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2018 | 3035 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 2009 | 889 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 622 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2009 | 1418 | 0.070 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 164 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2017 | 7238 | 0.070 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 980 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 7655 | 0.060 |
Why?
|
| T-Box Domain Proteins | 2 | 2017 | 154 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5574 | 0.060 |
Why?
|
| Chemokines | 1 | 2005 | 290 | 0.060 |
Why?
|
| Arthritis, Experimental | 1 | 2003 | 39 | 0.060 |
Why?
|
| Models, Immunological | 1 | 2003 | 79 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 617 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 117 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 2 | 2000 | 71 | 0.050 |
Why?
|
| Antibodies, Blocking | 2 | 2016 | 95 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2017 | 820 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 1109 | 0.050 |
Why?
|
| Male | 7 | 2021 | 128315 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2003 | 130 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 2471 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 1584 | 0.050 |
Why?
|
| Aneuploidy | 1 | 2023 | 382 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2007 | 1624 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2007 | 3584 | 0.050 |
Why?
|
| Immunization | 1 | 2003 | 399 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 1012 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 7265 | 0.050 |
Why?
|
| STAT Transcription Factors | 2 | 2013 | 80 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 1710 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 14849 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2015 | 294 | 0.040 |
Why?
|
| Cell Line | 3 | 2015 | 5338 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2000 | 151 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2019 | 27 | 0.040 |
Why?
|
| Arenaviridae Infections | 1 | 2019 | 4 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2019 | 19 | 0.040 |
Why?
|
| Peptide Library | 2 | 2014 | 148 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1999 | 244 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2022 | 672 | 0.040 |
Why?
|
| Diet, Atherogenic | 1 | 2017 | 19 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 7381 | 0.040 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2017 | 42 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 515 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 1999 | 335 | 0.040 |
Why?
|
| CD8 Antigens | 1 | 2017 | 174 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 411 | 0.030 |
Why?
|
| Cell Movement | 2 | 2015 | 2472 | 0.030 |
Why?
|
| Purinergic Agonists | 1 | 1996 | 1 | 0.030 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1996 | 9 | 0.030 |
Why?
|
| Saponins | 1 | 1996 | 48 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1726 | 0.030 |
Why?
|
| Panax | 1 | 1996 | 33 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1996 | 49 | 0.030 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2015 | 21 | 0.030 |
Why?
|
| Receptors, Interleukin-3 | 1 | 2015 | 27 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 693 | 0.030 |
Why?
|
| Rats | 3 | 2015 | 6441 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2015 | 130 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 683 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 382 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 738 | 0.030 |
Why?
|
| Models, Biological | 2 | 2017 | 3194 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2014 | 52 | 0.030 |
Why?
|
| Female | 9 | 2021 | 148940 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2017 | 487 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 264 | 0.030 |
Why?
|
| Cholesterol | 1 | 2017 | 659 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 172 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 1963 | 0.030 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptors, CCR7 | 1 | 2014 | 38 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 508 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 88 | 0.030 |
Why?
|
| Prodrugs | 1 | 2015 | 226 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 2617 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 7044 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2014 | 186 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 979 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2022 | 2027 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 319 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 1432 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 108 | 0.030 |
Why?
|
| Leishmania major | 1 | 2012 | 27 | 0.030 |
Why?
|
| Peyer's Patches | 1 | 2012 | 31 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 1097 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2016 | 699 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2012 | 174 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1032 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2017 | 732 | 0.020 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2012 | 54 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2011 | 61 | 0.020 |
Why?
|
| Histones | 1 | 2019 | 1513 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2012 | 197 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2012 | 314 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 1741 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2196 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 4878 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 1563 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 904 | 0.020 |
Why?
|
| Mice, Inbred CBA | 2 | 2000 | 79 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 1075 | 0.020 |
Why?
|
| Calcium | 1 | 1996 | 1578 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2009 | 70 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 2453 | 0.020 |
Why?
|
| Cell Migration Inhibition | 1 | 2008 | 16 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 61 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2009 | 97 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 181 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2009 | 166 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 4567 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 2090 | 0.020 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2008 | 23 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2007 | 30 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1199 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 201 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 6867 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 90352 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 4942 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 5056 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 737 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 494 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5315 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1525 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 2386 | 0.020 |
Why?
|
| Isoantigens | 1 | 2006 | 66 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2009 | 1028 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 404 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 3063 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 3046 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2010 | 1474 | 0.020 |
Why?
|
| Homeostasis | 1 | 2008 | 925 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 73333 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 3485 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 3117 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 82040 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2003 | 247 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 3476 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 2657 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2008 | 1654 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 6685 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3077 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 30998 | 0.010 |
Why?
|
| Melanoma | 1 | 2017 | 5595 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 1999 | 103 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 22505 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 318 | 0.010 |
Why?
|
| K562 Cells | 1 | 1999 | 344 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 2003 | 678 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1999 | 378 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 22251 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 6509 | 0.010 |
Why?
|
| Calcium Channel Agonists | 1 | 1996 | 15 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 4481 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1996 | 75 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 32767 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 4372 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 329 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 5759 | 0.000 |
Why?
|